Strategy for reduction of medical costs and growth of the healthcare industry after establishment of the national health insurance system in Japan: lessons for the Indonesian health care reform system -II-
Abstract
Japan has long operated a government-based health insurance system covering the entire population, and has been focusing on strategies for balancing viable national health care services with the need to minimize national health care expenditure. Hemodialysis (HD) is a representative form of medical treatment that is expected to expand in Indonesia in the near future, and which will require sustained financial support from the national health insurance system. In this report, consecutive to our previous one, we describe how the Japanese government has attempted to minimize medical expenditure in the past, focusing especially on HD.
References
Sawada T, Kawahara H. Cost of hemodialysis after coverage by national health insurance in Japan - A sharing experience with Indonesian reform system. Med J Indones. 2014;23(2):122-124. http://dx.doi.org/10.13181/mji.v23i2.652
Aichi Association for Dialysis. http://www.aichi-toseki.net/file/12/hirasawa.pdf.
Minister of Health, Labor and Welfare, Japan. http://www.mhlw.go.jp/toukei/saikin/hw/iryosd/10/dl/shisetsu.pdf.
E-Stat. http://www.e-stat.go.jp/SG1/estat/List.do?lid=000001060228
Minister of Health, Labor and Welfare, Japan. http://www.mhlw.go.jp/wp/hakusyo/kousei/07/dl/0101.pdf.
Minister of Health, Labor and Welfare, Japan. http://www.mhlw.go.jp/wp/hakusyo/kousei/10-2/kousei-data/PDF/22010209.pdf.
Mizuho Corporate Bank. http://www.mizuhobank.co.jp/corporate/bizinfo/industry/sangyou/pdf/1021_03.pdf.
Copyright (c) 2014 Tokihiko Sawada, Hirohisa Kawahara
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.
